| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $76.5M | +12.3% |
| SG&A Expense | $21.3M | +27.8% |
| Operating Income | -$97.7M | -15.3% |
| Pre-tax Income | -$90.6M | -15.3% |
| Income Tax | -$617K | -945.2% |
| Net Income | -$90.0M | -14.4% |
| EPS (Basic) | -$2.85 | +13.6% |
| EPS (Diluted) | -$2.85 | +13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.4M | -38.8% |
| Short-term Investments | $70.8M | +138.8% |
| Current Assets | $123.8M | +9.8% |
| Total Assets | $150.9M | +5.5% |
| Current Liabilities | $16.7M | -4.8% |
| Total Liabilities | $32.3M | -6.8% |
| Stockholders' Equity | $118.6M | +9.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.4M | -19.4% |
| Capital Expenditures | $497K | -80.9% |
| Investing Cash Flow | -$37.7M | -17.7% |
| Financing Cash Flow | $88.7M | — |
| Free Cash Flow | -$82.9M | -15.7% |